Ironwood Pharmaceuticals Q4 Adj. EPS $(0.01) Misses $0.01 Estimate, Sales $47.709M Miss $50.933M Estimate
Benzinga Newsdesk 8 months ago
EarningsEarnings MissesNews
Ironwood Pharmaceuticals (NASDAQ:IRWD) reported quarterly losses of $(0.01) per share which missed the analyst consensus estimate of $0.01 by 200 percent. This is a 200 percent decrease over earnings of $0.01 per share
Ironwood Pharmaceuticals (NASDAQ:IRWD) reported quarterly losses of $(0.01) per share which missed the analyst consensus estimate of $0.01 by 200 percent. This is a 200 percent decrease over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $47.709 million which missed the analyst consensus estimate of $50.933 million by 6.33 percent. This is a 47.31 percent decrease over sales of $90.545 million the same period last year.